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Summary
We report the identification of a new locus for gener-
alized epilepsy with febrile seizures plus (GEFS+). Six
family members manifested isolated typical febrile sei-
zures (FS), and five had typical FS associated with gen-
eralized epilepsy (FS+, generalized tonic/clonic seizures).
Afebrile seizures occurred from childhood until the teen-
age years. The maximum two-point LOD score was 3.99
for markers D2S294 and D2S2314. Flanking markers
place the GEFS+ locus between D2S141 and D2S116,
with multipoint analysis favoring the 13-cM interval
spanned by D2S294 and D2S364. This locus is the sec-
ond GEFS+ locus to be reported, which suggests that
this syndrome is genetically heterogeneous.
Introduction
Febrile seizures (FS [MIM 601087]) are common, af-
fecting 2%–5% of children between 6 mo and 6 years
of age. Seizures occur in normally healthy children, in
cases of fever with body temperature 138C. Seizures
are not associated with developmental delay, intracranial
infection, or any disease known to cause epilepsy, such
as tumor, cranial traumatism, etc. (Lennox 1949). Most
of the children present with a single episode. However,
a small percentage of children experience recurrent FS
(Berg 1997), and some of these go on to develop epilepsy,
especially idiopathic generalized epilepsy (IGE [MIM
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600669]) (Doose and Maurer 1997) and temporal lobe
epilepsy (Maher and McLachlan 1995).
The precise cause of FS is unknown. However, the
existence of familial cases supports the idea that FS have
a genetic factor (Frantzen et al. 1970). The main genetic
study was performed by Rich et al. (1987), who con-
cluded that FS were transmitted as a dominant auto-
somal trait in 30% of cases and as a polygenic trait in
other cases.
Some families appear to be clinically heterogeneous,
with cases of isolated FS, isolated epilepsy, or FS asso-
ciated with epilepsy, especially IGE. Genetic factors are
also implicated in the etiology of IGE. Indeed, IGE is
up to 95% concordant in monozygotic twins (Berkovic
et al. 1998), and close relatives of IGE probands fre-
quently present with IGE, with seizures similar or dif-
ferent from those of the probands (Tsuboi and Endo
1977). Genetic studies of IGE have shown that the risk
to first-degree relatives of IGE probands is ∼5%–10%,
versus !3% to controls (Beck-Mannagetta and Janz
1991). A family with several cases of generalized epilepsy
with febrile seizures plus (GEFS) has been extensively
described in a recent article (Scheffer and Berkovic
1997), and this description was later completed by stud-
ies of nine further pedigrees (Singh et al. 1999).
One of these GEFS pedigrees has recently been
linked to a missense mutation (C387G transversion in
exon 3) in the sodium-channel b1-subunit gene (SCN1B
[MIM 600235]), which maps to chromosome 19q (Wal-
lace et al. 1998). This mutation results in the replace-
ment of a highly conserved cysteine with a tryptophan
(C121W).
Five putative loci for phenotypes, in which FS occur,
have been published as being involved in six pedigrees:
FEB1 on chromosome 8q13-q21 (Wallace et al. 1996),
chromosome 2 (Lopes-Cendes et al. 1996), chromosome
11 (Anderson et al. 1995), FEB2 on chromosome 19p
(Johnson et al. 1998; Kugler et al. 1998), and chro-
mosome 19q (Wallace et al. 1998).
We performed a genomewide search for a novel FS
locus in a French family with GEFS and observed link-
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Table 1
Clinical Data
Patient
Age at First FS
(mo)
FS after
6 Years Afebrile Seizures
I 01 ) No Unknowna
I 02 Unknownb No No
II 01 12 No No
II 03 1 Yes GTCS, A
II 12 12 No No
II 13 36 Yes No
III 01 36 Yes No
III 03 7 Yes HCS
III 04 12 Yes No
III 05 7 Yes A, GTCS, AtS
III 09 7 No GTCS
III 10 7 Yes A, GTCS, AtS
III 11 36 ? No
NOTE.—A = absence seizures, AtS = atonic seizures, and
HCS = hemicorporeal clonic seizures.
a May have presented with GTCS in childhood. No-
body was able to confirm these facts, and no clinical re-
cords were available.
b Treated in childhood, with phenobarbital, for “nerv-
ous breakdown.” Nobody was able to confirm these facts,
and no clinical records were available.
age of the disorder to a group of microsatellite markers
located on chromosome 2q24-q33.
Patients, Material, and Methods
Family Ascertainment and Diagnostic Classification
Each member was directly interviewed (by D.C.) to
determine the occurrence and the type of seizure (table
1). Individuals were considered affected when either clin-
ical records or at least one close relative (generally, the
mother) confirmed that they presented between the ages
of 6 mo and 6 years with clonic, tonic/clonic, or atonic
seizures associated with fever. The diagnosis of other
seizure types was made according to the classification of
epileptic seizures (Commission on Classification and Ter-
minology of the International League against Epilepsy
1981). Family members who had presented with signs
or symptoms that were suggestive of epileptic seizures
but were not confirmed by at least one relative or by
clinical records from previous hospitalizations were con-
sidered to be of unknown disease status. Informed con-
sent was obtained from all study participants. This study
has been approved by the ethics committee of the Pe-
diatric Department of the Geneva University Hospital.
Genotyping and Linkage Analysis
DNA was extracted from peripheral blood leukocytes
by use of the Nucleon BACC 2 kit (Amersham). Micro-
satellite DNA polymorphisms were amplified by PCR
with the following conditions in a final volume of 25
ml: 100 ng DNA, 20 pmol each primer, 200 mM each
dNTP, 1.5 mM MgCl2, and 1.5 U Taq polymerase with
2.5 ml of the correspondent buffer (Eurobio). Both the
primers used and their annealing conditions were those
reported by Dib et al. (1996). Samples were amplified
in a thermocycler (Biometra), with the following con-
ditions: 95C for 3 min; then 30 cycles of 30 s at 92C,
30 s of annealing, and 30 s at 72C. PCR products were
loaded with a 10-pb ladder, on a 10% polyacrylamide
gel. The observed alleles were numbered according to
Ge´ne´thon.
Two-point linkage analyses were performed by the
MLINK subroutine of the LINKAGE program, and mul-
tipoint linkage analyses were performed by the LINK-
MAP subroutine of the LINKAGE program (Lathrop et
al. 1985), with the model used by Wallace et al. (1998):
autosomal dominant model of disease inheritance (be-
cause of a male-to-male transmission), with a disease-
allele frequency of .01, a phenocopy rate of .03, and a
genetic penetrance of .90 for LOD-score calculations.
Marker-allele frequencies were those estimated in the
CEPH reference families.
Results
Clinical Analysis
Seizures were diagnosed in 12 living subjects, includ-
ing 11 relatives and a spouse. Febrile seizures often lasted
for 120 min, without focalization or motor deficiency
(except in three relatives), and therefore did not meet
complex FS criteria. The fever was often mild (38C,
38.5C). The mean number of attacks was ∼5 (range
2–20).
Five family members presented with afebrile seizures
associated with FS until their teenage years (mean 11
years). These seizures were generalized or hemicorpo-
real, tonic/clonic or atonic absence attacks. Neurological
examination showed normal findings. Interrictal elec-
troencephalograms were normal except in three patients,
in whom generalized spike-and-wave discharges arose a
few years after the onset of FS.
The first seizure occurred sooner in patients with both
FS and other types of seizures (mean 5.8 mo, range 1–7
mo) than in those with FS only (mean 24 mo, range
12–36 mo).
The paternal grandfather (I 01) may have had child-
hood generalized tonic/clonic seizures (GTCS), and the
paternal grandmother (I 02) was treated with pheno-
barbital for “nervous breakdown” for a few months in
childhood. However, nobody was able to confirm these
facts, and no clinical records were available. Thus, these
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Table 2
Chromosome 2 Linkage Analysis Results
MARKER
LOD SCORE AT v =
MAXIMUM
LOD
SCORE
MAXIMUM
v0 .01 .05 .1 .2 .3 .4
D2S151 1.49 1.43 .88 .38 .10 .19 .11 .19 .3
D2S2236 1.00 .94 .38 .10 .48 .44 .23 .46 .2
D2S2299 .62 .63 .66 .64 .52 .33 .11 .66 .05
D2S141 .85 .09 .59 .88 .92 .71 .35 .92 .2
D2S156 1.16 1.14 1.05 .93 .69 .41 .14 1.16 0
D2S382 1.94 1.90 1.76 1.58 1.19 .76 .29 1.94 0
D2S294 3.99 3.93 3.67 3.33 2.58 1.75 .82 3.99 0
D2S326 3.63 3.57 3.33 3.01 2.33 1.57 .72 3.63 0
D2S2314 3.99 3.93 3.67 3.33 2.58 1.75 .82 3.99 0
D2S364 3.13 3.08 2.87 2.60 2.00 1.33 .60 3.13 0
D2S389 2.31 2.27 2.07 1.82 1.28 .70 .19 2.31 0
D2S117 2.99 2.97 2.85 2.65 2.12 1.45 .67 2.99 0
D2S116 2.09 .14 .43 .58 .55 .37 .15 .58 .1
subjects were considered to be of unknown disease
status.
Exclusion Analysis
We tested linkage to microsatellite polymorphisms lo-
cated at known idiopathic epilepsy or FS loci (juvenile
myoclonic epilepsy on chromosomes 6p (Greenberg et
al. 1988) and 15q (Elmslie et al. 1997), benign familial
neonatal convulsions on chromosomes 20q (Leppert et
al. 1989) and 8q (Lewis et al. 1993), benign familial
infantile convulsions on chromosome 19q (Guipponi et
al. 1997), FS on chromosomes 8q, 11q, and 19) (An-
derson et al. 1995; Wallace et al. 1996, 1998; Johnson
et al. 1998; Steinlein 1998). We observed negative LOD
scores for markers flanking and within these loci (data
not shown). These data indicated that the disorder in
this kindred was not linked to these known epilepsy loci.
Genomewide Search for a Novel GEFS Locus
We then undertook genomewide genetic-linkage anal-
ysis to identify the novel GEFS locus in this family.
We analyzed 257 microsatellite polymorphisms from the
Ge´ne´thon linkage map (Dib et al. 1996), spaced 5–20
cM throughout the autosomal chromosomes, for linkage
with the disorder in this GEFS kindred. We observed
positive LOD scores for individual markers located on
chromosomes 2 and 17: for D2S382, 1.41 (recombi-
nation fraction [v] 0), and for D17S1824, 1.48 (v =
). Then, nine additional markers on chromosome 2.05
and four on chromosome 17 were studied. We observed
significantly negative LOD scores for markers as close
as 1–2 cM from the chromosome 17 locus (data not
shown). These data indicated that the positive LOD
score for D17S1824 was simply random association ob-
served in a relatively small kindred.
Four of the nine additional markers on chromosome
2—namely, D2S294, D2S326, D2S2314, and D2S364—
yielded two-point LOD scores 13.0 (table 2). The gen-
otypes for all markers with no recombination and for
the two adjacent flanking markers showing obligate re-
combinants at D2S141 and D2S117 are shown with the
pedigree in figure 1.
Multipoint linkage analysis was performed for the dis-
ease locus and two adjacent markers at a time, sequen-
tially, for all markers from D2S382 to D2S117. Pub-
lished distances between these markers were obtained
from Ge´ne´thon (Dib et al. 1996). Multipoint linkage
analysis produced a maximum LOD score of 4.16 at
D2S294 and favored the 13-cM interval spanned by
D2S294 and D2S364.
Discussion
We identified a new locus for GEFS on chromosome
2q within a French family. Previous physical mapping
of the microsatellite markers allows us to assign this
locus to chromosome 2q24-q33. At present, our data
localize this region to a 30-cM interval between D2S141
and D2S117. This interval seems to overlap with that
of the chromosome 2–linked GEFS Australian pedi-
gree (Lopes-Cendes et al. 1996; G. Rouleau, personal
communication).
With identification of FS loci on chromosome 8q (Wal-
lace et al. 1996), 19p (Johnson et al. 1998; Kugler et al.
1998), and 19q (Wallace et al. 1998), it is possible to
compare phenotypes in families in which the disorder is
linked to each of these loci. In our pedigree, almost half
the affected relatives (5/11) presented with afebrile sei-
zures (atonic seizures, hemicorporeal seizures, absences,
and GTCS) with FS, whereas, in 19p-linked families, FS
were isolated. In the 8q-linked pedigree, very few family
members (3/19) have afebrile seizures (including one case
of temporal lobe epilepsy with hippocampal sclerosis).
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Figure 1 Pedigree of French GEFS family showing haplotype analysis for 13 markers on chromosome 2q. Markers are listed top to
bottom from centromere to telomere. For each marker, the alleles are numbered on the basis of sizes reported on CEPH families (Ge´ne´thon).
Novel alleles were assigned numbers after the last reported in the Ge´ne´thon database. Circles denote females, squares denote males, a slashed
symbol denotes a deceased subject, blackened symbols denote GEFS patients, half-blackened symbols denote isolated FS patients, a question
mark (?) denotes possible seizures reported by relatives (no medical records), a bracketed subject denotes an adopted child, and bracketed allele
numbers denote deduced alleles. The boldfaced bars represent the GEFS haplotype. An arrow indicates the proband.
The penetrance of the trait seems to be higher (∼90%)
in 2q-linked GEFS pedigrees (Lopes-Cendes et al.
1996; the present one) than in other families affected by
GEFS (Scheffer and Berkovic 1997; Wallace et al.
1998; Singh et al. 1999) or by FS (Johnson et al. 1998;
Kugler et al. 1998).
On the contrary, the frequency of isolated FS (11%
in the Australian family vs. 50% in the French family)
and the severity of the epileptic syndromes seems to be
different between 2q-linked GEFS families. This must
be confirmed by analyzing new 2q-linked GEFS
pedigrees.
Within the candidate region there is a three-gene clus-
ter of great interest. The three genes of this cluster encode
sodium-channel a-subunits (SCN1A, 2q24; SCN3A,
2q24.3; and SCN2A1, 2q31). Two other potential can-
didate channel subunit genes (sodium-channel a6-sub-
unit gene SCN6A, 2q21-q23 and calcium-channel b4-
subunit gene CACNB4, 2q22-q23) were excluded by
centromeric recombinants. One sodium channel subunit
is already known to be involved in GEFS (SCN1B,
Wallace et al. 1998). Thus, the analysis of this three-
gene cluster is under way in the French family with FC.
In conclusion, we identified, in a French pedigree, a
new locus for GEFS. It maps to chromosome 2q24-
q33 and spans a 30-cM candidate region bounded by
markers D2S141 and D2S116. In the near future, this
candidate region will be tested in other families with FS
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and GEFS, and the sodium-channel gene cluster map-
ping to 2q24-q33 will be screened for mutations in those
chromosome 2q–linked pedigrees.
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